Key result
Patients with acute coronary syndrome and CRP levels >22 mg/L had a higher 30-day mortality compared to those with CRP levels <22 mg/L (19.6% vs 6.5%).
Why the study?
Does elevated C-reactive protein correlate with increased 30-day mortality in patients with acute coronary syndrome?
Observational (n=250)
No
Does elevated C-reactive protein correlate with increased 30-day mortality in patients with acute coronary syndrome?
Absolute Event Rate: 19.6% vs 6.5%
Elevated C-reactive protein levels (>22 mg/L) are associated with a substantially higher risk of 30-day mortality in patients presenting with acute coronary syndrome.
No takes yet. Share an insight, caveat, or question.
CRP levels may signal higher 30-day mortality in ACS; leaves open incremental prognostic value beyond standard markers.
Maqbool et al. (2017) conducted an observational in Acute coronary syndrome (n=250). Elevated C-reactive protein (CRP > 22mg/L) vs. CRP < 22mg/L was evaluated on 30 day mortality. Patients with acute coronary syndrome and CRP levels >22 mg/L had a higher 30-day mortality compared to those with CRP levels <22 mg/L (19.6% vs 6.5%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: